Alan M. Reynard

810 total citations · 1 hit paper
19 papers, 699 citations indexed

About

Alan M. Reynard is a scholar working on Molecular Biology, Pharmacology and Molecular Medicine. According to data from OpenAlex, Alan M. Reynard has authored 19 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Molecular Medicine. Recurrent topics in Alan M. Reynard's work include Antibiotic Resistance in Bacteria (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Alan M. Reynard is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Alan M. Reynard collaborates with scholars based in United States and United Kingdom. Alan M. Reynard's co-authors include Louis F. Hass, Paul D. Boyer, Y.S. Bakhle, John R. Vane, Martin Beck, Cedric M. Smith, R. K. Cunningham, Robert E. Handschumacher and Ellis T. Bolton and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Alan M. Reynard

19 papers receiving 598 citations

Hit Papers

The Correlation of Reaction Kinetics and Substrate Bindin... 1961 2026 1982 2004 1961 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan M. Reynard United States 12 395 84 79 79 75 19 699
Liliana Mora France 21 1.2k 2.9× 68 0.8× 69 0.9× 54 0.7× 123 1.6× 59 1.6k
Bernard Schoot France 17 568 1.4× 32 0.4× 14 0.2× 52 0.7× 38 0.5× 27 1.0k
Manuel Garrigos France 17 508 1.3× 71 0.8× 89 1.1× 23 0.3× 17 0.2× 28 998
Daniel Gigot Belgium 22 851 2.2× 50 0.6× 25 0.3× 249 3.2× 156 2.1× 35 1.5k
P.T. Erskine United Kingdom 21 929 2.4× 50 0.6× 42 0.5× 37 0.5× 43 0.6× 49 1.3k
Robert T. Fischer United States 17 665 1.7× 65 0.8× 11 0.1× 91 1.2× 40 0.5× 20 965
Ellen Hildebrandt United States 18 382 1.0× 51 0.6× 44 0.6× 73 0.9× 26 0.3× 28 936
Adorján Aszalós United States 20 556 1.4× 41 0.5× 21 0.3× 20 0.3× 31 0.4× 65 1.2k
Henrianna Pang Canada 20 518 1.3× 52 0.6× 193 2.4× 22 0.3× 45 0.6× 26 1.6k
Galina Kalashnikova Russia 5 733 1.9× 52 0.6× 26 0.3× 37 0.5× 74 1.0× 8 1.3k

Countries citing papers authored by Alan M. Reynard

Since Specialization
Citations

This map shows the geographic impact of Alan M. Reynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan M. Reynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan M. Reynard more than expected).

Fields of papers citing papers by Alan M. Reynard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan M. Reynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan M. Reynard. The network helps show where Alan M. Reynard may publish in the future.

Co-authorship network of co-authors of Alan M. Reynard

This figure shows the co-authorship network connecting the top 25 collaborators of Alan M. Reynard. A scholar is included among the top collaborators of Alan M. Reynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan M. Reynard. Alan M. Reynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Smith, Cedric M. & Alan M. Reynard. (1991). Textbook of Pharmacology. Medical Entomology and Zoology. 58 indexed citations
2.
Reynard, Alan M., et al.. (1985). Inhibition of serum bactericidal reaction by lipopolysaccharide. Infection and Immunity. 48(3). 759–762. 10 indexed citations
3.
Reynard, Alan M.. (1980). The Regulation of Complement Activity by Pharmacologic Agents. PubMed. 2(1). 1–47. 9 indexed citations
4.
Reynard, Alan M., et al.. (1978). Potentiation of Antibiotic Bactericidal Activity by Normal Human Serum. Antimicrobial Agents and Chemotherapy. 13(5). 820–826. 49 indexed citations
5.
Reynard, Alan M., Martin Beck, & R. K. Cunningham. (1978). Effects of antibiotic resistance plasmids on the bactericidal activity of normal rabbit serum. Infection and Immunity. 19(3). 861–866. 12 indexed citations
6.
Reynard, Alan M., et al.. (1977). Effect of entry exclusion on mating aggregates and transconjugants. Journal of Bacteriology. 129(1). 131–137. 7 indexed citations
7.
Reynard, Alan M. & Martin Beck. (1976). Plasmid-mediated resistance to the bactericidal effects of normal rabbit serum. Infection and Immunity. 14(3). 848–850. 27 indexed citations
8.
Beck, Martin, et al.. (1975). Tetracycline Resistance in Escherichia coli Isolates from Hospital Patients. Antimicrobial Agents and Chemotherapy. 8(4). 488–494. 3 indexed citations
9.
Reynard, Alan M., et al.. (1972). Uptake of tetracycline by Escherichia coli: Lack of binding of tetracycline to the uptake system. Biochemical and Biophysical Research Communications. 48(5). 1129–1132. 12 indexed citations
10.
Reynard, Alan M., et al.. (1971). Uptake of 3 H-Tetracycline by Resistant and Sensitive Escherichia coli. Applied Microbiology. 21(1). 71–75. 15 indexed citations
11.
Reynard, Alan M., et al.. (1971). Uptake of 3H-Tetracycline by Resistant and Sensitive Escherichia coli. Applied Microbiology. 21(1). 71–75. 7 indexed citations
12.
Bakhle, Y.S. & Alan M. Reynard. (1971). Characteristics of the Angiotensin I Converting Enzyme from Dog Lung. Nature New Biology. 229(6). 187–189. 23 indexed citations
13.
Bakhle, Y.S., Alan M. Reynard, & John R. Vane. (1969). Metabolism of the Angiotensins in Isolated Perfused Tissues. Nature. 222(5197). 956–959. 139 indexed citations
14.
Reynard, Alan M.. (1968). THE REVERSIBLE AND IRREVERSIBLE INHIBITION OF N1-METHYLNICOTINAMIDE UPTAKE INTO RAT KIDNEY CORTEX SLICES. Journal of Pharmacology and Experimental Therapeutics. 163(2). 461–467. 6 indexed citations
15.
Reynard, Alan M. & Robert E. Handschumacher. (1967). The decarboxylation of 5‐azaorotic acid. Journal of Heterocyclic Chemistry. 4(3). 453–457. 2 indexed citations
16.
Reynard, Alan M., et al.. (1964). AN ANALYSIS OF THE LACK OF DRUG SYNERGISM DURING SEQUENTIAL BLOCKADE OF DE NOVO PYRIMIDINE BIOSYNTHESIS.. PubMed. 24. 1002–7. 31 indexed citations
17.
Reynard, Alan M., et al.. (1961). The Correlation of Reaction Kinetics and Substrate Binding with the Mechanism of Pyruvate Kinase. Journal of Biological Chemistry. 236(8). 2277–2283. 241 indexed citations breakdown →
18.
Hass, Louis F., Paul D. Boyer, & Alan M. Reynard. (1961). Studies on Possible Phosphoryl Enzyme Formation in Catalysis by Hexokinase, Pyruvate Kinase, and Glucose 6-Phosphatase. Journal of Biological Chemistry. 236(8). 2284–2291. 29 indexed citations
19.
Bolton, Ellis T. & Alan M. Reynard. (1954). Utilization of purine and pyrimidine compounds in nucleic acid synthesis by Escherichia coli. Biochimica et Biophysica Acta. 13(3). 381–385. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026